MedTrace Logo

Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects

NCT01145066 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-07-18

Study results available
· View outcomes & findings →

Summary

This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.

Conditions

Interventions

DRUG

borage/echium oil combination

borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA

DIETARY_SUPPLEMENT

fish oil

1.6g/day EPA and 1.08g/day DHA

DIETARY_SUPPLEMENT

corn oil

contains 4.5 g/day linoleic acid

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Floyd(Ski) H Chilton, Ph.D. · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-03-31
Completion
2011-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145066 on ClinicalTrials.gov